Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Journal of Clinical Medicine|April 28, 2023
Treatment Advances in Sepsis and Septic Shock: Modulating Pro- and Anti-Inflammatory MechanismsAdriana Marques, Carla Torre, Rui Pinto, et al.
Critical Reviews in Oncology/Hematology|April 13, 2024
Tumor mutational burden in colorectal cancer: Implications for treatmentAdriana Marques, Patrícia Cavaco, Carla Torre, et al.
Expert Opinion on Drug Safety|February 24, 2025
Review of studies evaluating the effectiveness of risk minimization measures for oncology medicinal products registered in the European Medicines Agency (HMA-EMA) catalogue: findings and lessons learnedJorge Monteiro, Diogo Almeida, João Paulo Fernandes, et al.
Critical Reviews in Oncology/Hematology|December 21, 2025
Impact of Adding Immune Checkpoint Inhibitors to Standard Therapies in Non-Small Cell Lung Cancer: A Systematic Review of Efficacy OutcomesAna Pinto Correia, Adriana Marques, Bruno Sepodes, et al.
Orphanet Journal of Rare Diseases|January 23, 2017
Evolving prevalence of haematological malignancies in orphan designation procedures in the European UnionBenedetta Polsinelli, Stelios Tsigkos, Frauke Naumann-Winter, et al.
Clinical and Experimental Gastroenterology|October 2, 2018
Hemin reduces inflammation associated with TNBS-induced colitisVanessa Mateus, João Rocha, Hélder Mota-Filipe, et al.
Human Resources for Health|January 7, 2022
A review of the continuous professional development system for pharmacistsJorge P B Batista, Carla Torre, José Manuel Sousa Lobo, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 26, 2025
Real-World Data Included in Post-authorisation Measures: A Case Study of Approved Advanced Therapy Medicinal Products in the European Union between 2013 and 2024Diogo Almeida, Diana Mandslay, Peter G M Mol, et al.
Pharmacology|October 2, 2017
Thiadiazolidinone-8 Ameliorates Inflammation Associated with Experimental Colitis in MiceVanessa Mateus, João Rocha, Paula Alves, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|November 8, 2022
A cross-country utilization patterns comparison of high expenditure therapeutic groups between Portugal and six European countries: the two sides of the Portuguese coinInês Martinho, António Teixeira Rodrigues, José Guerreiro, et al.
Pageof 8